184 related articles for article (PubMed ID: 8642061)
1. Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis.
Perrin PJ; Scott D; Davis TA; Gray GS; Doggett MJ; Abe R; June CH; Racke MK
J Neuroimmunol; 1996 Mar; 65(1):31-9. PubMed ID: 8642061
[TBL] [Abstract][Full Text] [Related]
2. B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis.
Perrin PJ; Scott D; June CH; Racke MK
Immunol Res; 1995; 14(3):189-99. PubMed ID: 8778209
[TBL] [Abstract][Full Text] [Related]
3. Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T-cell costimulatory pathway.
Shanafelt MC; Kang I; Barthold SW; Bockenstedt LK
Infect Immun; 1998 Jan; 66(1):266-71. PubMed ID: 9423867
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of acute passive murine encephalomyelitis II. Th1 phenotype of the inducing population is not sufficient to cause disease.
Lyons JA; Zhao ML; Fritz RB
J Neuroimmunol; 1999 Jan; 93(1-2):26-36. PubMed ID: 10378866
[TBL] [Abstract][Full Text] [Related]
5. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
[TBL] [Abstract][Full Text] [Related]
6. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
7. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.
Racke MK; Scott DE; Quigley L; Gray GS; Abe R; June CH; Perrin PJ
J Clin Invest; 1995 Nov; 96(5):2195-203. PubMed ID: 7593605
[TBL] [Abstract][Full Text] [Related]
9. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection.
Lumsden JM; Roberts JM; Harris NL; Peach RJ; Ronchese F
J Immunol; 2000 Jan; 164(1):79-85. PubMed ID: 10604996
[TBL] [Abstract][Full Text] [Related]
10. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
Kuchroo VK; Das MP; Brown JA; Ranger AM; Zamvil SS; Sobel RA; Weiner HL; Nabavi N; Glimcher LH
Cell; 1995 Mar; 80(5):707-18. PubMed ID: 7534215
[TBL] [Abstract][Full Text] [Related]
11. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.
Zheng P; Wu Y; Guo Y; Lee C; Liu Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6284-9. PubMed ID: 9600957
[TBL] [Abstract][Full Text] [Related]
12. Break of neonatal Th1 tolerance and exacerbation of experimental allergic encephalomyelitis by interference with B7 costimulation.
Bell JJ; Min B; Gregg RK; Lee HH; Zaghouani H
J Immunol; 2003 Aug; 171(4):1801-8. PubMed ID: 12902480
[TBL] [Abstract][Full Text] [Related]
13. CD80 expression is induced on activated B cells following stimulation by CD86.
Sahoo NC; Rao KV; Natarajan K
Scand J Immunol; 2002 Jun; 55(6):577-84. PubMed ID: 12028560
[TBL] [Abstract][Full Text] [Related]
14. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.
Hurwitz AA; Sullivan TJ; Krummel MF; Sobel RA; Allison JP
J Neuroimmunol; 1997 Mar; 73(1-2):57-62. PubMed ID: 9058759
[TBL] [Abstract][Full Text] [Related]
15. Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation.
Vandenborre K; Van Gool SW; Kasran A; Ceuppens JL; Boogaerts MA; Vandenberghe P
Immunology; 1999 Nov; 98(3):413-21. PubMed ID: 10583602
[TBL] [Abstract][Full Text] [Related]
16. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance.
Eagar TN; Karandikar NJ; Bluestone JA; Miller SD
Eur J Immunol; 2002 Apr; 32(4):972-81. PubMed ID: 11920563
[TBL] [Abstract][Full Text] [Related]
17. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
Vaughan AN; Malde P; Rogers NJ; Jackson IM; Lechler RI; Dorling A
J Immunol; 2000 Sep; 165(6):3175-81. PubMed ID: 10975832
[TBL] [Abstract][Full Text] [Related]
18. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics.
Larché M; Till SJ; Haselden BM; North J; Barkans J; Corrigan CJ; Kay AB; Robinson DS
J Immunol; 1998 Dec; 161(11):6375-82. PubMed ID: 9834128
[TBL] [Abstract][Full Text] [Related]
19. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4: a negative regulator of autoimmune disease.
Karandikar NJ; Vanderlugt CL; Walunas TL; Miller SD; Bluestone JA
J Exp Med; 1996 Aug; 184(2):783-8. PubMed ID: 8760834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]